Accuray launches CyberKnife platform in Africa for cancer patients

Sep. 30, 2022 9:24 AM ETAccuray Incorporated (ARAY)By: Dania Nadeem, SA News Editor
  • Accuray (NASDAQ:ARAY) said it had launched its CyberKnife platform in Africa for more patients to receive treatments with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) the system delivers.
  • CyberKnife platform can treat certain neurologic conditions and a wide range of tumor types throughout the body, and at various stages of disease.
  • The entire CyberKnife procedure is typically completed in just 1 to 5 out-patient sessions, providing a shorter overall course of treatment compared to conventional radiation therapy which typically takes 30-40 sessions.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.